About
The Nagoya Protocol at Its 10th Anniversary: Lessons Learned and New Challenges from ‘Access and Benefit-Sharing’
Soon a new global tax on products developed from “digital information” from biological materials? 5 key takeaways for companies from recent UN negotiations
New EU Wastewater Treatment Fees on Producers of Pharmaceutical and Cosmetic Products

WIPO proposes new Patent Disclosure obligations on Genetic Resources: What impact for companies?
Pathogen Access and Benefit-Sharing (P-ABS) under the draft WHO Pandemic Treaty: Why Many Vaccine, Therapeutic, and Diagnostic Companies will be in Scope
Historic Marine Biodiversity Treaty creates new Access and Benefit-Sharing obligations for life sciences companies
EU Pharma Legislation Review Series: Decentralized Manufacturing

EU Pharma Legislation Review Series: Supply Security and Shortages Control
